PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-01-10

Date Title Company
10-Jan-2025 Tiziana Announces Reduction of Side Effects Commonly Seen with Discontinuation of GLP-1 Agonists with Nasal Anti-CD3 Tiziana Life Sciences
10-Jan-2025 iTeos Announces 2025 Strategic Priorities and Anticipated Milestones iTeos Therapeutics
10-Jan-2025 SYNBIOTIC with four new investments in 2024: Further acquisitions in sight for 2025 SYNBIOTIC SE
10-Jan-2025 Aston University researchers seek participants for newly funded study into medication weight gain Aston University
10-Jan-2025 Biotech Startups Get a Boost: ZAGENO and Hatch.Bio Labs Partner to Streamline Lab Operations ZAGENO
10-Jan-2025 MitoRx Therapeutics Expands Leadership Team with Strategic Appointments of Chief Business Officer and Finance Director MitoRx Therapeutics
10-Jan-2025 David Schilansky Appointed Chief Financial Officer of Ariceum Therapeutics Ariceum Therapeutics
10-Jan-2025 Cytosurge Announces Strategic Leadership Transition Cytosurge AG
10-Jan-2025 Synaffix and Mitsubishi Tanabe Pharma Sign License Agreement for ADC Technology Synaffix B.V.
10-Jan-2025 Boehringer Ingelheim Acquires Fourth License for the Development of Novel Antibody Based Cancer Treatments from Oxford BioTherapeutics Oxford BioTherapeutics (OBT)
10-Jan-2025 Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology Boehringer Ingelheim
10-Jan-2025 PureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML) PureTech
10-Jan-2025 New drug hope for prostate cancer patients The Institute of Cancer Research
10-Jan-2025 Accure Therapeutics partner Oculis reached positive phase 2 results for lead neuroprotective therapy Andrew Lloyd Associates
10-Jan-2025 Biogen Appoints Adam Feire as Head of Business Development and External Innovation Biogen
10-Jan-2025 Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology Boehringer Ingelheim
10-Jan-2025 New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma Sanofi
10-Jan-2025 Labcorp and Inspira Health Announce Strategic Agreement for Lab Operations Labcorp
10-Jan-2025 Thermo Fisher Scientific’s Olink Platform Selected for World’s Largest Human Proteome Study Thermo Fisher Scientific
10-Jan-2025 Danaher Announces Investment Partnership in Innovaccer Inc. Danaher